Tauriga Sciences Inc. Approved to Operate Virtual Exhibitor Booth at PGA Merchandise Show 2021 — January 26th- 29th 2021

January 20, 2021 Off By GlobeNewswire

1_21 PR

Tauriga Sciences Inc. Exhibitor Booth at 2020 PGA Merchandise Show

Tauriga Sciences Inc. Exhibitor Booth at 2020 PGA Merchandise Show

The Company Will Showcase Its Flagship Brand, Tauri-Gum™, as Well as Its Expanded Product Offerings

NEW YORK, NY, Jan. 20, 2021 (GLOBE NEWSWIRE) —  via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it will operate a Virtual Exhibitor Booth (“Virtual Booth”) at the Professional Golfers’ Association (“PGA”) Merchandise Show 2021, which takes place on January 26th– 29th, 2021.  Last year, the Company operated a successful and highly visited Corporate Exhibitor Booth (#4507) at the PGA Merchandise Show 2020 – which took place in Orlando, Florida (January 21st– 24th, 2020).  The Company has established many important relationships, throughout the golf industry, as a result of the positive exposure from last year’s Tradeshow.

The Company currently sells its Tauri-Gum™ product line to a number of golf pro shops and industry themed stores.  Additionally, the Company has received online E-Commerce order(s) from professional golfer(s).  Moving forward, the Company plans to further penetrate this large market segment (golf industry), during calendar year 2021 and beyond.   

In other news, the Company is pleased to confirm that it has received its 5,000thE-Commerce order (on January 19th, 2021).  The average order size ($ dollar amount), per individual online E-Commerce transaction, has been steadily increasing over the past months. The Company is confident that its highest margin E-Commerce business segment will continue to experience meaningful levels of growth.   

Lastly, the Company has officially launched an improved and updated version of its corporate website (www.tauriga.com).  This website version also includes the Company’s updated power point presentation (please click on the “Who We Are” tab). (Read more…)  

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative.  This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”.  On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company’s clinical development efforts.

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)

The Company is headquartered in Wappingers Falls, New York.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

DISCLAIMER — Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

4 Nancy Court, Suite 4

Wappingers Falls, NY 12590

Chief Executive Officer

Mr. Seth M. Shaw

Email:  [email protected]

cell # (917) 796 9926

Company Instagram: @taurigum

Personal Instagram:  @sethsms47

Twitter: @SethMShaw

Corp. Website:   www.tauriga.com

E-Commerce Website:  www.taurigum.com

Attachment